Excessive sedation is a "serious safety concern" with an experimental, long-acting form of Eli Lilly's Zyprexa schizophrenia medicine, U.S. drug reviewers said in an analysis released today.
Food and Drug Administration staff said the injectable formulation, called Zyprexa Adhera, was shown to be effective for acute and long-term treatment of schizophrenia, Reuters and Bloomberg both reported.
But risks include excessive sleepiness.
The analysis was released ahead of a meeting by a panel of outside advisers who will evaluate the drug on Wednesday.
More
Food and Drug Administration staff said the injectable formulation, called Zyprexa Adhera, was shown to be effective for acute and long-term treatment of schizophrenia, Reuters and Bloomberg both reported.
But risks include excessive sleepiness.
The analysis was released ahead of a meeting by a panel of outside advisers who will evaluate the drug on Wednesday.
More
1 comment:
I believe I've read that ER docs have said that the regular Zyprexa shot can cause death. Considering that, and looking at the destruction caused by the pills, let's hope the vote for this junk money maker is a resounding NO
Post a Comment